Ages2Come
Menu
View all results →
Categories
⚡ Breaking
X will now tell users when governments have forced it to limit their posts Aviation regulators turn to AI to help manage the nation's airspace OpenAI joins call for US-led global AI standards Dyson Won't Say What's Wrong With Its CameraJet Toothbrush FAA halts flights to Newark, Philadelphia, New York because of equipment problem Stock boom is fueling a ‘retirement party,’ economists say — what it means for workers Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production NASA Discovery Reveals Complex Water Systems on Early Mars Oura’s $2.2B IPO is mostly a payday for existing shareholders Paramount makes concessions to salvage $111 billion Warner Bros. Discovery deal X will now tell users when governments have forced it to limit their posts Aviation regulators turn to AI to help manage the nation's airspace OpenAI joins call for US-led global AI standards Dyson Won't Say What's Wrong With Its CameraJet Toothbrush FAA halts flights to Newark, Philadelphia, New York because of equipment problem Stock boom is fueling a ‘retirement party,’ economists say — what it means for workers Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production NASA Discovery Reveals Complex Water Systems on Early Mars Oura’s $2.2B IPO is mostly a payday for existing shareholders Paramount makes concessions to salvage $111 billion Warner Bros. Discovery deal
Business / General

Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production

Source: cnbc September 21, 2026 · 09:59
Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production
Photo by https://kaboompics.com/ · Pexels
Read original article ← Back to General

The original article opens on the publisher's website.

More from General

View topic →